Jump to content

Diamyd Medical

Edit links
From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Bon courage (talk | contribs) at 14:52, 18 November 2024 (Restored revision 1209175290 by Pablo.pk23 (talk): Unsourced/promotional). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Diamyd Medical AB (Stockholm NASDAQ, First North) is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.

Diamyd Medical logo

The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå.[1]

[edit]


References

[edit]
  1. ^ "Annual Report 2021/2022" (PDF). Diamyd Medical AB. Retrieved 20 February 2023.
Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=Diamyd_Medical&oldid=1258173884"